In a report released today, Andrew Semple from Echelon Wealth Partners maintained a Buy rating on Indiva (NDVAF – Research Report), with a price target of C$0.50. The company's shares closed last Thursday at $0.19, close to its 52-week low of $0.16. According to TipRanks.com, Semple is a 3-star analyst with an average return of 4.0% and a 25.0% success rate. Semple covers the Basic Materials sector, focusing on stocks such as Ascend Wellness Holdings LLC, Green Thumb Industries, and Fire & Flower Holdings. Indiva has an analyst consensus of Moderate Buy, with a price target consensus of $0.43.
https://www.tipranks.com/news/blurbs/indiva-ndvaf-receives-a-buy-from-echelon-wealth-partners-2?utm_source=advfn.com&utm_medium=referral
Indiva (QX) (USOTC:NDVAF)
Historical Stock Chart
From Jul 2022 to Aug 2022 Click Here for more Indiva (QX) Charts.
Indiva (QX) (USOTC:NDVAF)
Historical Stock Chart
From Aug 2021 to Aug 2022 Click Here for more Indiva (QX) Charts.